Short O-GalNAc glycans: regulation and role in tumor development and clinical perspectives

Joanne Chia1, Germaine Goh1, Frederic Bard2

  • 1Institute of Molecular and Cell Biology, 61 Biopolis Drive, Proteos, 138673, Singapore.

Abstract

Insights

Cancer cells exhibit altered O-GalNAc glycans (Tn and TF antigens), not due to incomplete processes but activated regulatory pathways. Understanding this regulation, particularly the GALA pathway, is key for cancer diagnostics and therapeutics.

Area of Science:

  • Biochemistry
  • Cancer Biology
  • Glycobiology

Background:

  • Cancer development involves genetic modifications and altered cellular states, notably changes in glycosylation.
  • Tumor cells frequently over-express O-GalNAc glycans, specifically Tn and TF antigens, though the mechanisms remain unclear.
  • Simple explanations like altered glycosylation enzyme levels do not fully account for the observed antigen overexpression.

Purpose of the Study:

  • To elucidate the regulatory mechanisms of O-GalNAc glycosylation initiation and extension.
  • To introduce the GALA pathway, a novel concept involving enzyme compartmentation in regulating Tn antigen levels.
  • To discuss the implications of O-GalNAc glycans and their regulatory enzymes (GALNTs) in cancer and explore diagnostic/therapeutic potential.

Main Methods:

  • Focus on the initiating enzymes of O-GalNAc glycosylation, polypeptide N-acetylgalactosaminyltransferases (ppGalNAcTs or GALNTs).
  • Description of the GALA pathway, detailing changes in GALNTs compartmentation within the secretory pathway.
  • Analysis of the roles of O-GalNAc glycans and GALNTs in tumorigenic processes.

Main Results:

  • Contrary to previous hypotheses, elevated short O-glycans in tumors indicate activated regulatory pathways, not incomplete glycosylation.
  • High Tn antigen levels signify a substantial shift in the O-glycoproteome, rather than a mere shortening of glycans.
  • These significant glycan alterations are driven by underlying membrane trafficking events.

Conclusions:

  • The study challenges the notion of incomplete glycosylation as the cause of short O-glycans in tumors.
  • Activation of specific regulatory pathways, including the GALA pathway, is responsible for altered O-glycan expression.
  • A deeper mechanistic understanding of O-GalNAc glycan regulation is crucial for developing effective biomarkers, antibodies, and therapeutic vaccines for cancer.

Related Concept Videos

Proteoglycans01:05

Proteoglycans

Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
5.1K
Protein Glycosylation01:25

Protein Glycosylation

Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
10.4K
Oligosaccharide Assembly01:24

Oligosaccharide Assembly

Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
3.8K